Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;36(11):e5465.
doi: 10.1002/bmc.5465. Epub 2022 Aug 12.

RP-HPLC method development, validation and pharmacokinetic applicability in preclinical evaluation of rhein treated with novel diacerein eutectics

Rajeshri D Patel  1 , Mihir K Raval  2 , Trupesh M Pethani  3 , Bhargav N Waghela  4 , Riddhi H Shukla  1 , Prakruti R Buch  3 , Jigna M Vadalia  5 , Tejas P Sharma  3 , Vishal A Airao  3
Affiliations

RP-HPLC method development, validation and pharmacokinetic applicability in preclinical evaluation of rhein treated with novel diacerein eutectics

Rajeshri D Patel et al. Biomed Chromatogr. 2022 Nov.

Abstract

The current study represents a bioanalytical method for the estimation of rhein (Rh, an active metabolite of diacerein, DIA) in rats treated with novel DIA eutectics to investigate the pharmacokinetics of DIA. A simple protein precipitation technique was used to extract Rh and the internal standard (IS), p-aminobenzoic acid, injected into a Phenomenex Gemini C18 column. The separation was achieved by a gradient elution comprising ammonium acetate (10 mm; pH 3.0) and acetonitrile in an 18 min run time at a flow rate of 0.8 ml/min with retention times of 11.8 min (Rh) and 5.9 min (IS). The results revealed that the proposed method is linear over a range of 200-20,000 ng/ml (r2 > 0.9988) of Rh and is precise and accurate. The method was fully validated as per the US Food and Drug Administration guidelines and a pharmacokinetic study in rats was performed for Rh following oral administration of the pure DIA and newly developed eutectics. Therefore, the present method could be used to estimate DIA to illustrate a comparative pharmacokinetic analysis. This can also be applied to its related multicomponent formulations for future studies.

Keywords: RP-HPLC; diacerein; eutectic; pharmacokinetics; rhein.

PubMed Disclaimer

References

REFERENCES

    1. Aggarwal, A. K., & Singh, S. (2011). Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000. Drug Development and Industrial Pharmacy, 37(10), 1181-1191. https://doi.org/10.3109/03639045.2011.563782
    1. Batt, D. K., & Garala, K. C. (2013). Preparation and evaluation of inclusion complexes of diacerein with β-cyclodextrin and hydroxypropyl β-cyclodextrin. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 77(1-4), 471-481. https://doi.org/10.1007/s10847-012-0268-8
    1. Braggio, S., Barnaby, R. J., Grossi, P., & Cugola, M. (1996). A strategy for validation of bioanalytical methods. Journal of Pharmaceutical and Biomedical Analysis, 14(4), 375-388. https://doi.org/10.1016/0731-7085(95)01644-9
    1. Chakrabarty, U. S., Mandal, U., Bhaumik, U., Chatterjee, B., Ghosh, A., Bose, A., & Pal, T. K. (2008). Bioequivalence study of two capsule formulations containing diacerein 50 mg in healthy human subjects. Arzneimittel-Forschung, 58(08), 405-409.
    1. Cherukuvada, S. (2016). On the issues of resolving a low melting combination as a definite eutectic or an elusive cocrystal: A critical evaluation. Journal of Chemical Sciences, 128(4), 487-499. https://doi.org/10.1007/s12039-016-1055-7

LinkOut - more resources